BFBIO · BF Biosciences Limited
BF Biosciences Limited Board Meeting Notice for Q1 Financial Results
Official PSX filing title: Board Meeting
- Filed
- 20 October 2026 at 11:13 am
- Category
- Meetings
- Sentiment
- Neutral
- Impact
- Low
Executive summary
BF Biosciences Limited has announced that a meeting of its Board of Directors will be held on October 27, 2026, to consider the quarterly financial results for the period ended September 30, 2026, and any potential entitlements. A closed period is in effect from October 20 to October 27, 2026.
Key takeaways
- Board meeting scheduled for October 27, 2026
- Will review financial results for the period ended September 30, 2026
- Closed period set from October 20 to October 27, 2026
Filing details
Board meeting
- Status
- Scheduled
- Meeting date
- 27 October 2026 at 5:00 pm
- Purpose
- To consider quarterly financial results and potential entitlements
- Closed period
- 20 October 2026 – 27 October 2026
- Consider the Quarterly Financial Results for the period ended 2026-09-30
- Declaration of any entitlement
- #board meeting
- #financial results
- #closed period
- #bfbio
Please cross-check with the official PSX filing before making an investment decision.